Adora Ndu

Insider Reports History

Entity
Individual
Location
C/O Dbv Technologies S.A., 177 181 Avenue Pierre Brossolette, Montrouge, France
Signature
/s/ Jennifer J. Rhodes, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Adora Ndu:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ACADIA PHARMACEUTICALS INC Director Common Stock 11K $187K $16.94 May 29, 2024 Direct
ACADIA PHARMACEUTICALS INC Director Restricted Stock Units 9.39K $159K $16.94 May 29, 2024 Direct
DBV Technologies S.A. Director Ordinary Shares 1.83K $1.62K $0.89 Feb 6, 2024 Direct
ACADIA PHARMACEUTICALS INC Director Director Stock Options (Right to Buy) 16K May 29, 2024 Direct

Insider Reports Filed by Adora Ndu

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ACAD ACADIA PHARMACEUTICALS INC May 29, 2024 4 $0 4 May 31, 2024 Director
DBVT DBV Technologies S.A. Feb 6, 2024 1 $1.62K 4 Feb 8, 2024 Director
ACAD ACADIA PHARMACEUTICALS INC Oct 12, 2023 2 $0 4 Oct 16, 2023 Director
ACAD ACADIA PHARMACEUTICALS INC Jun 1, 2023 2 $0 4 Jun 5, 2023 Director
ACAD ACADIA PHARMACEUTICALS INC Oct 12, 2022 2 $0 4 Oct 14, 2022 Director
ACAD ACADIA PHARMACEUTICALS INC Oct 12, 2022 0 $0 3 Oct 14, 2022 Director
DBVT DBV Technologies S.A. Jun 10, 2021 1 $48.7K 4 Jun 11, 2021 Director
DBVT DBV Technologies S.A. May 19, 2021 0 $0 3 Jun 1, 2021 Director